Dr. Giridhar P. Kalamangalam, MD

Dr. Kalamangalam practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Kalamangalam's NPI, 1164478111, was assigned on May 25, 2006. Dr. Kalamangalam graduated from Jawaharlal Institute of Postgraduate Medical Education and Research in 1989. Dr. Kalamangalam holds Florida license MFC1789.

Dr. Kalamangalam's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Kalamangalam's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalamangalam practices. Vendor and product names are available with a free account.

Neurology is Dr. Kalamangalam's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Kalamangalam's licenses on file in 3 states: Florida, Texas and Ohio.

Dmand AI lists epilepsy and seizures among the conditions Dr. Kalamangalam treats.

CMS data shows 155 Medicare services from Dr. Kalamangalam across 5 procedure codes in 2024, for 135 Medicare patients. Medicare paid $17,845 for them.

CMS counts 135 Medicare patients who saw Dr. Kalamangalam in 2024. The largest group is under 65, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kalamangalam's median patient age at 67, with 40% women.

In 2024, Dr. Kalamangalam wrote 467 Medicare Part D claims for 72 patients. 77% of them were for generic drugs. CMS names the drug for 368 of them, across 14 drugs with 11 or more claims each, at $125,322 in total drug cost. In 2023, CMS named 216 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Kalamangalam for performance year 2024, reported through an alternative payment model (APM). Dr. Kalamangalam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kalamangalam as offering telehealth.

Dmand AI links 61 papers to Dr. Kalamangalam, published from 2007 to 2025. 2016 was the busiest year, with 5. The most frequent topics are Electroencephalography, Brain and Epilepsy. Dr. Kalamangalam has published most often in J Clin Neurophysiol. Dr. Kalamangalam's most frequent co-authors are Nitin Tandon, MD, Jeremy D. Slater, MD and Samden Dorjee Lhatoo, MD.

CMS Open Payments shows 22 general payments to Dr. Kalamangalam from 7 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 59% of the total. Lundbeck LLC paid the most, $3,561.

Dmand AI lists 1 award for Dr. Kalamangalam, most recently CMS Stage 1 2012 in 2012.

Dr. Kalamangalam graduated from Jawaharlal Institute of Postgraduate Medical Education and Research in 1989.

Dr. Kalamangalam is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.